One dose of swine flu vaccine sufficient: Sinovac

Sparse details of the world’s first clinical trial of a swine flu vaccine emerged Tuesday, with Chinese manufacturer Sinovac reporting that a single dose of its vaccine produces a good immune response.

Sparse details of the world’s first clinical trial of a swine flu vaccine emerged Tuesday, with Chinese manufacturer Sinovac reporting that a single dose of its vaccine produces a good immune response.

But the company did not reveal key details, including the size of the dose or the formulation of the vaccine, information that would be needed to determine whether other vaccine makers could expect to see similar results.

Authorities are anxious to learn more about the trial, conducted in 1,641 people aged three years and older in China.

“WHO looks forward to reviewing as soon as possible detailed immunogenicity results from the Sinovac clinical trial,” Dr. Marie-Paule Kieny, head of the World Health Organization’s vaccine research initiative, said via email.

“They can bring precious early information on what H1N1 vaccine formulations seem to be effective.”

The Sinovac release said the pandemic vaccine was well tolerated by participants with no signs of serious side-effects. The adverse reactions that were reported were similar to those seen with seasonal flu vaccine administration, it said, with a sore arm being the most common complaint.

“As demonstrated in the clinical trial of our H1N1 vaccine, we can confirm the immunization schedule and dosage, which can provide the scientific reference to the state government to establish the inoculation strategy of H1N1 vaccine,” Sinovac president and CEO Weidong Yin said in the release.

“Sinovac plans to complete the summary report as soon as possible and fully evaluate the safety and immunogenicity of the H1N1 vaccine.”

The director of the U.S. National Institute of Allergy and Infectious Diseases said news that a single dose might be adequate to protect against the virus is a hopeful sign, but cautioned against drawing any conclusions until more is known about the trial and its findings.

“This is encouraging news if in fact the product that they used is similar to the product that we’re using, number 1, and number 2, if the data backs up the statement that they gave to the press,” Dr. Anthony Fauci said from Bethesda, Md.

He said Sinovac should share its data.

“I’d like to see the data. I’d like to know . . . did they really have an adequate immune response to just one dose? If so, that’s great news, I’m glad to hear that. But we need to see the data.”

A flu vaccine expert at the University of Rochester, N.Y., echoed Fauci’s caution, but said it is plausible that one shot may suffice for at least a portion of the population.

“I think at a certain age you’re going to respond to a single dose probably pretty well,” said Dr. John Treanor, chief of infectious diseases at the University of Rochester Medical Center.

“I don’t know what that age cut-off is. Who knows? Maybe everybody will respond to a single dose. That’s one of the big unanswered questions right now.”

An earlier release from the company said Sinovac would study several dose sizes, ranging from five to 30 micrograms.

Seasonal flu shots contain 15 micrograms for each virus type they protect against. But it could not be assumed that a standard dose would be sufficient to protect against a new virus, one to which most people under 55 or 60 have little or no immunity.

Sinovac had also announced it would study vaccines made in different ways, one using whole viruses and the other using viruses that had been broken down or split. (In both cases the viruses are killed, or in the language of vaccine makers, inactivated.)

Just Posted

Random Acts of Green Canadian tour comes to Red Deer

Red Deerians are being encouraged to lessen their impact on the environment.… Continue reading

Free blood testing for HIV, Hep C, syphilis offered Thursday in Red Deer

Anyone can drop by from 10 a.m. to 4 p.m. at Bower Ponds pavilion

Red Deer economy bouncing back but slowly: report

While Red Deer’s economy has been in recovery mode for the past… Continue reading

Red Deer cyclist dead after being hit by vehicle

A Red Deer cyclist was killed when he was struck by a… Continue reading

Support for retaining ‘public’ in Alberta school titles could snowball, says local trustee

Even districts that never had the word in their titles are now discussing adding it

WATCH: 2019 Canada Winter Games will leave a lasting legacy, say organizers

It leaves Red Deer with the infrastructure and confidence to host future such events

Your community calendar

Wednesday Central Alberta Historical Society annual general meeting is 6 p.m. at… Continue reading

Couche-Tard wants to be a player in the sale of cannabis

LAVAL, Que. — Alimentation Couche-Tard Inc. wants to be one of the… Continue reading

Michael Dawe: A safe supply of water has long been a priority for Red Deer

The oldest part of the Red Deer water treatment plant on 54th… Continue reading

New parent charged in admissions scam, linked to $400K bribe

BOSTON — A woman accused of paying $400,000 to get her son… Continue reading

Canadian stars Virtue, Moir say in video they’re “stepping away” from ice dancing

Canadian ice dancing stars Tessa Virtue and Scott Moir say they are… Continue reading

Bruce Cockburn avoids impulse to get political with lyric-less new album

TORONTO — If anyone is looking for activist folk singer Bruce Cockburn… Continue reading

13 seasons in, stars reflect on success of ‘Heartland,’ Canada’s ‘comfort food’

HIGH RIVER, Alta. — Alberta-born actor Shaun Johnston had already had a… Continue reading

N.S. senior whose birthday card request drew international response dies

SYDNEY, N.S. — A Nova Scotia widower who received thousands of birthday… Continue reading

Most Read